13F Pro13F Pro

Lisanti Capital Growth, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1424467
Institutional-grade research for retail investors

Sector Allocation

  • Technology39.3%$178.6M
  • Healthcare23.0%$104.7M
  • Industrials18.9%$85.9M
  • Consumer Discretionary7.4%$33.7M
  • Financials4.0%$18.4M
  • Energy3.6%$16.4M
  • Materials1.9%$8.7M
  • Communication Services1.1%$4.8M
  • Utilities0.4%$1.7M
  • Consumer Staples0.4%$1.7M

AUM History

13fpro.ai/research/fund/lisanti-capital-growth-llc-1424467

Conviction and streaks

Diversifying · top 10 = 19.1%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

HNGE$HNGEConviction hold2.5% weight · held 5 quartersBTSG$BTSGConviction hold2.4% weight · held 4 quartersFROG$FROGConviction hold1.6% weight · held 6 quartersCRS$CRSConviction hold1.6% weight · held 9 quartersDY$DYConviction hold1.6% weight · held 5 quartersHTFL$HTFLAccumulating+550% shares · 3 quarters runningVCEL$VCELAccumulating+373% shares · 3 quarters runningCORT$CORTAccumulating+98% shares · 2 quarters runningZETA$ZETAAccumulating+134% shares · 2 quarters runningCROX$CROXAccumulating+82% shares · 2 quarters runningROAD$ROADTrimming-68% shares · 6 quarters runningBOOT$BOOTTrimming-65% shares · 4 quarters runningRBC$RBCTrimming-27% shares · 3 quarters runningMOD$MODTrimming-63% shares · 3 quarters runningMRCY$MRCYTrimming-58% shares · 3 quarters running

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/lisanti-capital-growth-llc-1424467

Lisanti Capital Growth, LLC 13F holdings — Q2 2026

$454.6M portfolio (+14.6% QoQ) · 109 holdings · Q2 2026 13F · top 10 are 19% of the stock portfolio

All holdings — Lisanti Capital Growth, LLC (Q2 2026)

109 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
DY$DYDYCOM INDUSTRIES INC$7.2M-17%
KRYS$KRYSKrystal Biotech, Inc.$7.1M+3%
CVLT$CVLTCOMMVAULT SYSTEMS INC$7.0MNew
ADPT$ADPTAdaptive Biotechnologies Corp$7.0MNew
ZETA$ZETAZeta Global Holdings Corp.$6.9M+133%
RBC$RBCRBC Bearings INC$6.8M-17%
TVTX$TVTXTravere Therapeutics, Inc.$6.8M+147%
ENVA$ENVAEnova International, Inc.$6.7M+7%
FORM$FORMFORMFACTOR INC$6.6M+41%
UCTT$UCTTUltra Clean Holdings, Inc.$6.6M-23%
PVLA$PVLAPALVELLA THERAPEUTICS, INC.$6.6M+4%
SIMO$SIMOSilicon Motion Technology CORPadr$6.5M-22%
MOD$MODMODINE MANUFACTURING CO$6.4M-36%
CROX$CROXCrocs, Inc.$6.4MNew
GRDN$GRDNGuardian Pharmacy Services, Inc.$6.4M-19%

What changed in Q2 2026

Against the previous quarter's 13F: 50 new, 19 added to, 36 trimmed, 44 sold out. Share-count changes; largest moves by dollar size first.

New positions (50)

  • XMTR$XMTRXometry, Inc.$9.7M

    first bought this quarter

  • CORT$CORTCORCEPT THERAPEUTICS INC$8.0M

    first bought this quarter

  • ALGM$ALGMALLEGRO MICROSYSTEMS, INC.$7.5M

    first bought this quarter

  • CVLT$CVLTCOMMVAULT SYSTEMS INC$7.0M

    first bought this quarter

  • ADPT$ADPTAdaptive Biotechnologies Corp$7.0M

    first bought this quarter

  • CROX$CROXCrocs, Inc.$6.4M

    first bought this quarter

+44 more in the Excel export

Added to (19)

  • HNGE$HNGEHinge Health, Inc.+135%

    now $11.5M · held 5 qtrs

  • TVTX$TVTXTravere Therapeutics, Inc.+147%

    now $6.8M · held 4 qtrs

  • ZETA$ZETAZeta Global Holdings Corp.+133%

    now $6.9M · held 8 qtrs

  • KNSA$KNSAKiniksa Pharmaceuticals International, plc+181%

    now $5.6M · held 2 qtrs, 2 adds in a row

  • CECO$CECOCECO ENVIRONMENTAL CORP+118%

    now $6.1M · held 3 qtrs

  • MIRM$MIRMMirum Pharmaceuticals, Inc.+62%

    now $7.4M · held 2 qtrs, 2 adds in a row

+13 more in the Excel export

Trimmed (36)

  • STRL$STRLSTERLING INFRASTRUCTURE, INC.-86%

    now $2.1M · held 5 qtrs

  • MKSI$MKSIMKS INC-79%

    now $2.1M · held 2 qtrs

  • SITM$SITMSITIME Corp-73%

    now $2.4M · held 9 qtrs, 2 trims in a row

  • KNX$KNXKnight-Swift Transportation Holdings Inc.-62%

    now $4.0M · held 3 qtrs, 2 trims in a row

  • PL$PLPlanet Labs PBC-90%

    now $738K · held 3 qtrs

  • LGND$LGNDLIGAND PHARMACEUTICALS INC-51%

    now $5.9M · held 8 qtrs, 2 trims in a row

+30 more in the Excel export

Sold out (44)

  • FIVE$FIVEFIVE BELOW, INCwas $9.7M

    held 4 qtrs

  • PTEN$PTENPATTERSON UTI ENERGY INCwas $9.7M

    held 1 qtr

  • MTDR$MTDRMatador Resources Cowas $7.8M

    held 1 qtr

  • AEIS$AEISADVANCED ENERGY INDUSTRIES INCwas $7.7M

    held 3 qtrs

  • FN$FNFabrinetwas $6.3M

    held 1 qtr

  • ENSG$ENSGENSIGN GROUP, INCwas $6.2M

+38 more in the Excel export

Firm AUM (Form ADV): $432.5M as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F Lisanti Capital Growth, LLC has filed, 41 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Lisanti Capital Growth?

Q2 2026 13F filed with the SEC on Aug 10, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Lisanti Capital Growth's top 20 holdings: 59/100 (our AI quality score, weighted by position size; 19 of the 20 are scored)

Top 10 since filing

-7.6%

Value-weighted move of the 10 largest stock positions

Turnover

51%

Last quarter; 181% over the last 4

Top 10 weight

19%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

26%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Lisanti Capital Growth, LLC disclosed 109 positions worth $454.6M in its Form 13F-HR for Q2 2026, led by $HNGE (Hinge Health, Inc.) at 2.5% of the equity portfolio, followed by $BTSG and $XMTR. During the quarter the fund opened 50 new positions and exited 44 — including a new stake in $XMTR and a full exit from $FIVE. The portfolio is most concentrated in Technology (39.3% of disclosed assets). All figures are sourced directly from Lisanti Capital Growth, LLC’s Form 13F-HR filing with the SEC under CIK 1424467.

Funds like this

managers whose biggest positions overlap Lisanti Capital Growth's
OBERWEIS ASSET MANAGEMENT INC/$4.84B 13F book · 9 shared top holdingsDOCNBTSGHNGEUCTTEMERALD ADVISERS, LLC$4.25B 13F book · 9 shared top holdingsCORTTVTXCECOMIRMNEXT CENTURY GROWTH INVESTORS LLC$1.89B 13F book · 10 shared top holdingsXMTRMIRMRBCUCTTEMERALD MUTUAL FUND ADVISERS TRUST$2.85B 13F book · 9 shared top holdingsTVTXCORTCECOMODGranahan Investment Management, LLC$2.81B 13F book · 9 shared top holdingsCRSSIMOMODLGNDHood River Capital Management LLC$13.79B 13F book · 6 shared top holdingsDOCNKRYSXMTRLSCC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Lisanti Capital Growth, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For Lisanti Capital Growth, LLC (SEC CIK: 1424467), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Lisanti Capital Growth, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.